Use of Polymeric Excipients for Lyophilization or Freezing of Particles

Abraxis Bioscience, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2012/069585, filed Dec 13, 2012. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 9,585,960	Use of Polymeric Excipients for Lyophilization or Freezing of Particles Abraxis Bioscience, LLC In force Term ends Dec 13, 2032 · High confidence	Abraxis Bioscience, LLC	In force	Term ends Dec 13, 2032	Term ends Dec 13, 2032	High confidence
US 10,076,501	Use of Polymeric Excipients for Lyophilization or Freezing of Particles Abraxis Bioscience, LLC In force Ends no later than Dec 13, 2032 · Medium confidence	Abraxis Bioscience, LLC	In force	Ends no later than Dec 13, 2032	Ends no later than Dec 13, 2032	Medium confidence
US 10,555,912	Use of Polymeric Excipients for Lyophilization or Freezing of Particles Abraxis Bioscience, LLC In force Ends no later than Dec 13, 2032 · Medium confidence	Abraxis Bioscience, LLC	In force	Ends no later than Dec 13, 2032	Ends no later than Dec 13, 2032	Medium confidence

3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.